Cochrane · systematic review · CD013240

Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis

Georgiou, EX, Melo, P, Baker, PE, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

Gynaecology and FertilityAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 7 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Long‐term GnRH agonist therapy compared to no additional therapy in patients with endometriosis prior to standard in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI)

Population: patients with endometriosis prior to standard IVF/ICSI
7 questions
OutcomeEffectEvidenceStatus / GRADE
Live birth rate
Long‐term GnRH agonist therapy vs no additional therapy
RR 0.48 [0.26, 0.87]1 study · 147 participantsVery low
Complication rate
Long‐term GnRH agonist therapy vs no additional therapy
Peto OR 1.23 [0.37, 4.14]3 studies · 318 participantsVery low
Downgraded: imprecision, inconsistency
Clinical pregnancy rate
Long‐term GnRH agonist therapy vs no additional therapy
RR 1.13 [0.91, 1.41]6 studies · 552 participantsVery low
Downgraded: imprecision, inconsistency
Multiple pregnancy rate
Long‐term GnRH agonist therapy vs no additional therapy
Peto OR 0.14 [0.04, 0.56]2 studies · 208 participantsVery low
Downgraded: imprecision, inconsistency
Miscarriage rate
Long‐term GnRH agonist therapy vs no additional therapy
Peto OR 0.45 [0.1, 2]2 studies · 208 participantsVery low
Downgraded: imprecision, inconsistency
Mean number of oocytes
Long‐term GnRH agonist therapy vs no additional therapy
no estimate extracted4 studies · 385 participantsVery low
Downgraded: imprecision, inconsistency
Mean number of embryos
Long‐term GnRH agonist therapy vs no additional therapy
no estimate extracted2 studies · 267 participantsVery low
Downgraded: imprecision, inconsistency